Stay updated on GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.0.2 from v3.0.1; the 'Back to Top' link was removed. No substantive changes to pricing, stock, or core page content.SummaryDifference0.5%
- Check10 days agoChange DetectedThe page has been updated to reflect a new revision version (v3.0.1) and a new study status date of September 1, 2025, while the previous revision version (v3.0.0) and an earlier date of August 3, 2025, have been removed.SummaryDifference1%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference54%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated to a new version, v2.16.11, and the previous version, v2.16.10, has been removed. Additionally, a date of August 3, 2025, has been added.SummaryDifference1.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page.